Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Items 801–900 of 1,000
Afzal, S., Sattar, M. Z. A., Johns, E. J., & Eseyin, O. A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174218 · Cited by 11
Is Triglyceride-Glucose Index a Valuable Parameter in Peripheral Artery Disease?
Çalışkan, S., & Böyük, F. (2023) · Cureus · doi:10.7759/cureus.35532 · Cited by 11
“Moreover, an increase in levels of fibrinogen and thromboxane as well as platelet aggregation is observed in connection with the increased insulin level [7,8].”
BackgroundA therapeutic approach to treat cardiovascular dysfunction of diabetes
Bhatt, L. K., & Veeranjaneyulu, A. (2011) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2011.03.005 · Cited by 11
MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Drapkina, O. M., & Gegenava, B. B. (2013) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2013-9-1-62-65 · Cited by 11
Alpha Lipoic Acid Treatment Improved Endothelium-dependent Relaxation in Diabetic Rat Aorta
Okudan, N., Atalık, K. E. N., Gökbel, H., Canbilen, A. E., & Kara, İ. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.739 · Cited by 11
Marrachelli, V. G., Miranda, F. J., Centeno, J. M., Burguete, M. C., Castelló‐Ruiz, M., Jover‐Mengual, T., Pérez, A. M., Salom, J. B., Torregrosa, G., & Alborch, E. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.09.002 · Cited by 11
“Diabetes alters the responsiveness of different vascular beds to several vasoconstrictors and vasodilators, and it has been hypothesized that endothelial dysfunction could partially explain many of these altered responses [17,18].”
BackgroundStojanović, I. R., Djordjević, G., Pavlović, R., Djordjević, V. B., Pavlovic, D. D., Cvetković, T., Ljubisavljević, S., Bašić, J., & Zabar, K. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.09.026 · Cited by 11
“Superoxide anion interacts with NO, forming potent cytotoxin — peroxynitrite, which attacks different biomolecules in vascular endothelium, vascular smooth muscle, myocardium, perineurium and nerve tissue cells, resulting in the dysfunction of a variety of organs [8].”
BackgroundChin, L. C., Achike, F. I., & Mustafa, M. R. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.10.005 · Cited by 11
Pan, X.-F., Lai, Y., Gu, J., Wang, H., Liu, A., & Shan, Z. (2016) · Medicine · doi:10.1097/md.0000000000003253 · Cited by 11
Shigemoto, E., Iwata, A., Futami, M., Kato, Y., Yamashita, M., Imaizumi, S., Kuwano, T., Ike, A., Sugihara, M., Saku, K., et al. (2019) · Heart and Vessels · doi:10.1007/s00380-018-01334-5 · Cited by 11
Role of protein kinase C in diabetic complications
King, G. L., & Daş-Evcimen, N. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.74 · Cited by 11
Tetrahydrobiopterin in the vascular system
Walter, R. B., Schaffner, A., & Schoedon, G. (2001) · Pteridines · doi:10.1515/pteridines.2001.12.3.93 · Cited by 11
Regression of cardiac hypertrophy in type 2 diabetes with hypertension by candesartan
Iwashima, Y., Okada, M., Haneda, M., & Yoshida, T. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.03.032 · Cited by 11
“Besides the mechanisms described in Section 1 [5–7], enhanced activity of the tissue renin– angiotensin system, including hyperglycemia-induced increase in angiotensin II [18,19], and upregulation of myocardial AT1-R [20] have been reported in diabetes.”
BackgroundOliveira, M. A., de Carvalho, M. H. C., Nigro, D., Tostes, R. C., & Fortes, Z. B. (2003) · Peptides · doi:10.1016/s0196-9781(03)00061-5 · Cited by 11
Szabó, C. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc178 · Cited by 11
Microcirculatory parameters in compensated and decompensated type 2 diabetes mellitus
Suchkova, O. V., Gurfinkel, Y. I., & Сасонко, М. Л. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh2017891028-35 · Cited by 11
“[20], на фоне длительной хронической гипергликемии происходит подавление функции эндотелия.”
Miyatake, S., Hino, K., Ebisu, G., & Fujita, S. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101149 · Cited by 10
Soflaei, S. S., Nazar, E., Sahranavard, T., Fayedeh, F., Ghalibaf, A. M., Ebrahimi, M., Alimi, H., Shahri, B., Izadi‐Moud, A., Ferns, G. A., et al. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03649-2 · Cited by 10
“T2DM can contribute substantially to atherogenesis [33], thrombosis [34], and vascular damage [35], therefore leading to increased risks of IHD [36].”
BackgroundLockhart, C., McCann, A. J., Pinnock, R. A., Hamilton, P., Harbinson, M., & McVeigh, G. E. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00372.2014 · Cited by 10
Witcher, D., Sakai, N., Williams, B., Rahimian, R., & Anderson, L. C. (2010) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.06.013 · Cited by 10
Theodoropoulou, E., Chelioti, E., Revenas, K., Katsilambros, N. L., Kostakis, A. G., & Boletis, J. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.08.093 · Cited by 10
Restrepo, B., García, M., López, C., Martín, M. L., Román, L. S., & Morán, A. (2012) · Pharmacology · doi:10.1159/000341911 · Cited by 10
Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials
Silva‐Cardoso, J., Sheikh, O., Nashawi, M., Pham, S. V., Gallegos, K. M., Dinkha, L. R., & CHILTON, R. J. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.13007 · Cited by 10
“They are independent of and precede the development of macrovascular and atherosclerotic vascular disease.80,81 Most middle-aged type 2 diabetic patients develop earlyonset diastolic dysfunction, and this phenomenon is seen even in asymptomatic patients with the absence of clinically manifested vascular disease.40,69,…”
BackgroundFatehi‐Hassanabad, Z., Imenshahidi, M., Fatehi, M., Farrokhfall, K., & Heidar, P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.01.063 · Cited by 10
Sunagawa, M., Shimada, S., Hanashiro, K., Nakamura, M., & Kosugi, T. (2006) · Endothelium · doi:10.1080/10623320600972051 · Cited by 10
Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
Merlak, M., Kovačević, D., Balog, T., Marotti, T., Mišljenović, T., Mikulicić, M., & Dekaris, I. (2008) · PubMed · Cited by 10
Makita, S., Matsui, H., Naganuma, Y., Abiko, A., Tamada, M., & Nakamura, M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.033 · Cited by 10
Cruz, J. P. D. L., Moreno, A., Guerrero, A., Ortega, G., Correa, J. A. G., & de la Cuesta, F. S. (2002) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000057285 · Cited by 10
Boieriu, A. M., Luca, C. D., Neculoiu, C. D., Bisoc, A., & Ţînţ, D. (2025) · Medicina · doi:10.3390/medicina61010135 · Cited by 9
“Hyperglycemia induces repeated alterations of intracellular metabolism and long-term changes in the structure and function of molecules through the formation of advanced glycation end products [21].”
Zaharia, O., Schön, M., Löffler, L., Straßburger, K., Möser, C., Yurchenko, I., Bódis, K. B., Antoniou, S., Karusheva, Y., Szendroedi, J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac480 · Cited by 9
“In people with diabetes, several mechanisms may explain endothelial dysfunction, such as impaired NO release, disturbed expression of receptors, and receptor-coupled mechanisms involved in vasorelaxation, reduced availability of the substrates for NO synthesis, progressive reduction of circulating progenitor cells, en…”
BackgroundMarmarelis, V. Z., Shin, D. C., Yue, K., & Novak, V. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241254716 · Cited by 9
Shah, W., Gong, Y., Qiao, X., Lu, Y., Ding, Y., Zhang, Z., & Gao, Y. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04714-x · Cited by 9
“In rats with STZ-induced diabetes, folate demonstrated an acute improvement in endothelial dysfunction within the renal microcirculation [160].”
Bratkovsky, S., Aasum, E., Riemersma, R. A., Myhre, E. S. P., & Larsen, T. S. (2006) · Acta Physiologica · doi:10.1111/j.1748-1716.2006.01527.x · Cited by 9
“The lower CF reserve could alternatively reflect structural changes in the vessel wall because of the formation of advanced glycosylation end products (AGEs) (de Vriese et al. 2000, Sheetz & King 2002, Candido et al. 2003).”
BackgroundEzetimibe reduces intimal hyperplasia in rabbit jugular vein graft
Maekawa, T., Komori, K., Morisaki, K., & Itoh, T. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.05.071 · Cited by 9
Bankowski, H., Yi, F.-X., Boeldt, D. S., Krupp, J. L., Grummer, M. A., Shah, D. M., & Bird, I. M. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.128645 · Cited by 9
“It has been proposed that one particular issue with NO is its ability to react with reactive oxygen species (ROS) prevalent in the disease state, thereby resulting in the destruction of bioactive NO [7].”
BackgroundInfluentialDesrois, M., Lan, C., Movassat, J., & Bernard, M. (2017) · Nutrition & Metabolism · doi:10.1186/s12986-016-0157-z · Cited by 9
“Impaired endothelium-dependent vasorelaxation (EDV) has been observed in both type 1 and type 2 diabetes [28], wherever some studies have shown enhanced EDV in diabetes [29].”
BackgroundNwose, E. U., & Bwititi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.651776 · Cited by 9
Bakhtiari, M. K., Sharifiyazdi, H., Nazıfı, S., Ghaemi, M., & Zarandi, M. H. (2021) · PubMed Central · doi:10.22099/ijvr.2021.38416.5585 · Cited by 9
“Several mechanisms, such as hyperglycemia, have been implicated in reduced endothelium-derived NO availability and, at the same time, increased formation of oxidative stress in diabetes (De Vries et al., 2000).”
BackgroundGuzmn-Gutirrez, E., Arroyo, P., Pardo, F., Leiva, A., & Sobrevi, L. (2013) · InTech eBooks · doi:10.5772/55627 · Cited by 9
“[34] De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM.”
BackgroundNemoto, S., Taguchi, K., Matsumoto, T., Kamata, K., & Kobayashi, T. (2011) · Peptides · doi:10.1016/j.peptides.2011.11.018 · Cited by 9
Kumar, G. S., Shetty, S., Shetty, A., Amin, B., Raj, B., & Mithra, A. (2018) · International Journal of Prosthodontics and Restorative Dentistry · doi:10.5005/jp-journals-10019-1195 · Cited by 9
Bubb, K. J., Ritchie, R. H., & Figtree, G. A. (2018) · Microcirculation · doi:10.1111/micc.12501 · Cited by 9
Martínez, A. C., Hernández, M., Novella, S., Martínez, M. P., Pagán, R. M., Hermenegildo, C., García‐Sacristán, A., Prieto, D., & Benedito, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106372 · Cited by 9
“Several lines of evidence suggest that endothelial dysfunction could be a major contributor to both macro- and microangiopathy in DM patients and in animal models of diabetes [4,5].”
BackgroundCruz, J. P. D. L., Jebrouni, N., López-Villodres, J. A., Muñoz-Marín, J., Guerrero, A., & Correa, J. A. G. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1283 · Cited by 9
“Other abnormal pathways such as increases in endothelin synthesis or in protein kinase C and increased activity of the polyol pathway [22,23] may in turn influence several vasoactive factors and contribute to functional andmorphological changes in the retina in diabetes, suggesting that endothelial dysfunction is the…”
BackgroundJarrete, A. P., Zanesco, A., & Delbin, M. A. (2016) · Motriz Revista de Educação Física · doi:10.1590/s1980-65742016000100001 · Cited by 9
Nitrosative Stress and Pathogenesis of Insulin Resistance
Kaneki, M., Shimizu, N., Yamada, D., & Chang, K. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.9.ft-17 · Cited by 9
Abarca, B., Ballesteros, R., Bielsa, P., Moragues, J., D’Ocón, P., García‐Zaragozá, E., & Noguera, M. A. (2003) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(03)00057-6 · Cited by 9
MUSHTAQ, S., Ali, T., ALTAF, F., ABDULLAH, M., & Murtaza, I. (2015) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1308-25 · Cited by 9
Sensor of transdermal biomarkers for blood perfusion monitoring
Shekarriz, R., Friedrichsen, D., Brooks, B., Silaski, G., Rios, L., Wiest, E., & Kanagy, N. L. (2020) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2020.100328 · Cited by 9
Choy, J. C., Lui, A., Moien‐Afshari, F., Wei, K. S., Yanagawa, B., McManus, B. M., & Laher, I. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200401000-00007 · Cited by 9
“errant secretion from endothelium has been implicated in the pathogenesis of several cardiovascular diseases.(10,11) As such,”
BackgroundBrooks, B. A., Heffernan, S. J., Thomson, S. E., McLennan, S. V., Twigg, S. M., & Yue, D. K. (2008) · American Journal of Primatology · doi:10.1002/ajp.20550 · Cited by 9
Ibarra-Lara, L., Sánchez‐López, A., del Valle‐Mondragón, L., Soria‐Castro, E., Zarco-Olvera, G., Patlán, M., Guarner‐Lans, V., Torres-Narváez, J. C., Ruiz‐Ramírez, A., de León‐Sánchez, F. D., et al. (2025) · Antioxidants · doi:10.3390/antiox14040482 · Cited by 8
The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease
Guo, Z. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00609-1 · Cited by 8
“…in the occurrence of diabetic vascular complications, is prevalent in type 1 diabetes, type 2 diabetes, and experimental rodent models of diabetes [5] and is commonly accompanied by accumulation of advanced glycation end-products (AGEs) and activation of protein kinase C (PKC) and…”
Chen, G., Huang, L., Lai, M., & Ran, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-68208-x · Cited by 8
Hörber, S., Prystupa, K., Jacoby, J., Fritsche, A., Kleber, M. E., Moissl, A. P., Hellstern, P., Peter, A., März, W., Wagner, R., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02402-z · Cited by 8
“Besides this, vWF is widely recognized as a marker of endothelial dysfunction, an important pathophysiological process underlying cardiovascular disease in individuals with prediabetes and diabetes [34, 35].”
BackgroundAssociation of nitric oxide synthase 3 gene polymorphism with the risk of type 2 diabetes
Garme, Y., Saravani, R., & Galavi, H. R. (2017) · Biomedical Reports · doi:10.3892/br.2017.916 · Cited by 8
Kavak, S., Emre, M., Meral, İ., Unlugenc, H., Pelit, A., & Demirkazık, A. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000903009522 · Cited by 8
“Diabetes mellitus (DM) is associated with vascular complications such as impairments of vascular responsiveness to neurotransmitters in the various vascular tissues (De Vriese et al. 2000).”
BackgroundEffects of short-term hyperglycemia on the vasoconstriction of the aorta
Dönmez, S., Gökalp, O., DOĞAN, M., Vural, H., & Yiğit, B. (2014) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1307-121 · Cited by 8
Proteomic analysis reveals downregulation of housekeeping proteins in the diabetic vascular proteome
Dwinovan, J., Colella, A. D., Chegeni, N., Chataway, T., & Sokoya, E. M. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0929-y · Cited by 8
“In this way, blunted GPx3 can result in a reduction in NO bioavailability, a hallmark of endothelial dysfunction in the diabetic vasculature [35].”
TOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds
Naef, R., Tenor, H., & Koch, G. (2020) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2020.814 · Cited by 8
Sdogou, T., Kossiva, L., Kakleas, K., Platokouki, H., Tentolouri, T., Georgouli, H., Karayianni, C., & Karavanaki, K. (2013) · Hormone Research in Paediatrics · doi:10.1159/000343813 · Cited by 8
Effects of anthocyanidin derivative (HK-008) on relaxation in rat perfused mesenterial bed
Kamata, K., Makino, A., Kanie, N., Oda, S.-I., Matsumoto, T., Kobayashi, T., Kikuchi, T., Nishimura, M., & Honda, T. (2006) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.42.75 · Cited by 8
“…in the production and effects of these endothelial-cell products are at least partly responsible for the abnormal modulation of vascular tone that occurs in certain disease states (Kamata et al., 1989; Cohen, 1995; De Vriese et al., 2000; Matsumoto et al., 2003a,b, 2004e; Sekiguchi et al., 2004).”
BackgroundMori, A., Higashi, K., Wakao, S., Sakamoto, K., Ishii, K., & Nakahara, T. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1423-y · Cited by 8
“Impaired endothelium-dependent vasodilation has been observed in vascular beds of different animal models of diabetes and in diabetic humans as well (Oyama et al. 1986; Taylor et al. 1992; De Vriese et al. 2000).”
BackgroundKamata, K., Ozawa, Y., Kobayashi, T., & Matsumoto, T. (2009) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.45.125 · Cited by 8
“…is a well-established complication of diabetes mellitus (Oyama et al., 1986; Kamata et al., 1989; Poston and Taylor, 1995; Pieper, 1999; De Vriese et al., 2000; Matsumoto et al., 2003a, b, 2006a, 2008; Kobayashi et al., 2000, 2004, 2005), and a failure of the adaptive coronary flow…”
BackgroundContribution of EDHF and the role of potassium channels in the regulation of vascular tone
Ding, H., & Triggle, C. R. (2003) · Drug Development Research · doi:10.1002/ddr.10135 · Cited by 8
“Multiple mechanisms for a reduction in endothelium-dependent vasodilatation have been described, with an enhanced production of free radicals and a consequent reduction in the bioavailability of NO as the most likely cellular basis for dysfunction [De Vriese et al., 2000; Napoli and Ignarro, 2001].”
BackgroundEffect of Sulodexide on Vascular Responses and Liver Mitochondrial Function in Diabetic Rats
Dobiaš, L., Petrová, M., Vojtko, R., Uličná, O., Vančová, O., & Kristová, V. (2015) · Physiological Research · doi:10.33549/physiolres.933236 · Cited by 8
Scrimieri, R., Locatelli, L., Cazzola, R., Maier, J. A. M., & Cazzaniga, A. (2019) · PubMed · doi:10.1684/mrh.2019.0456 · Cited by 8
Recommendations for Special Populations: The Treatment of Hypertension in Diabetes Mellitus
Tan, A. S., Kuppuswamy, S., Whaley‐Connell, A. T., Kurukulasuriya, L. R., & Sowers, J. R. (2004) · The Endocrinologist · doi:10.1097/01.ten.0000146262.10013.e7 · Cited by 8
Thomas, G. N., McGhee, S. M., Schooling, C. M., Ho, S. Y., Lam, K. S. L., Janus, E. D., & Lam, T. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344143 · Cited by 8
Howes, L. G. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00469.x · Cited by 8
Faingold, I. I., Soldatova, Y. V., Poletaeva, D. A., Klimanova, E. N., & Санина, Н. А. (2023) · Membranes · doi:10.3390/membranes13070615 · Cited by 7
“Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease [12].”
BackgroundMyocardial Revascularization in Patients with Diabetes and Heart Failure—A Narrative Review
Živković, S., Mandić, A., Krupnikovic, K. S., Obradović, A. D., Mišević, V., Farkić, M., Ilić, I., Tesic, M. B., Aleksandric, S. B., Juričić, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073398 · Cited by 7
“However, in However, in patients with T2DM, insulin resistance impairs NO production, resulting in diminished vasodilation and endothelial dysfunction [27,28]. patients with T2DM, insulin Furthermore, diabetes is associated with increased levels of pro-inflammatory cytokines, such as TNF-α and IL-6.”
Ntekoumes, D., & Gerecht, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137416 · Cited by 7
Wang, C., Gao, Y., Smerin, D., Xiong, X., Chen, Z., & Gu, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112267 · Cited by 7
Milian, J., Goldfine, A. B., Zuflacht, J. P., Parmer, C. M., & Beckman, J. A. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0708-6 · Cited by 7
“vasodilator and vasoconstriction substances to maintain homeostasis [2].”
Metoprolol rescues endothelial progenitor cell dysfunction in diabetes
Yan, L., Dong, Y.-F., Qing, T.-L., Deng, Y., Han, X., Shi, W., Li, J.-F., Gao, F., Zhang, X., Tian, Y., et al. (2020) · PeerJ · doi:10.7717/peerj.9306 · Cited by 7
Exercise training protects the renal circulation against high glucose challenge
de Moraes, R., Gioseffi, G., Lopes, N. D. N., Gomes, M. B., da Nóbrega, A. C. L., & Tibiriçá, E. V. (2005) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00358.x · Cited by 7
Novel Stem Cell–Based Drug Discovery Platforms for Cardiovascular Disease
Adams, W. J., & García‐Cardeña, G. (2012) · SLAS DISCOVERY · doi:10.1177/1087057112454741 · Cited by 7
“Research has identified several potential mechanisms through which chronic hyperglycemia may induce endothelial dysfunction, including participation of advanced glycation end products, creating oxidative stress and insulin signaling, although many of the pathological mechanisms remain unknown.(82,83) Mitigating the en…”
BackgroundCacciapuoti, F. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0057 · Cited by 7
“7,8 The prothrombotic state in metabolic syndrome is favored by adipose tissue rich in several molecules, such as leptin, plasminogen activator inhibitor (PAI-1), angiotensinogen, and interleukin-6 (IL-6).”
Human internal thoracic arteries from diabetic patients are resistant to endothelial dysfunction
Grapow, M. T. R., Reineke, D. C., Kern, T., Müller‐Schweinitzer, E., Carrel, T. P., & Eckstein, F. S. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00707.x · Cited by 7
Lazaraki, G., Kountouras, J., Metallidis, S., Vrettou, E., Alevizos, M., Tzioufa, V., Dokas, S. M., Germanidis, G. S., Zavos, C., & Nikolaidis, P. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.06.011 · Cited by 7
“In diabetes mellitus (DM), evidence for a reduced NO ioactivity has been found [5] either due to a decreased NO roduction, a reduced availability of the substrate l-arginine or the NO producing enzyme, or an increased destruction f NO by reactive oxygen metabolites (ROMs).”
BackgroundObesity-Associated Hypertension
Uwaifo, G. I. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_13 · Cited by 7
Weber, B., & Hoerstrup, S. P. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-021-8_22 · Cited by 7
Correa, J. A. G., Arrebola, M. M., Muñoz-Marín, J., Moreno, A., Guerrero, A., Arranz, I., de la Cuesta, F. S., & Cruz, J. P. D. L. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2006.11.007 · Cited by 7
Hypertension in obese children and adolescents
Peco‐Antić, A. (2009) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0902091p · Cited by 8
Georgescu, A., Popov, D., & Simionescu, M. (2001) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2001.00047.x · Cited by 7
Activity of Angiotensin Peptides in Clitoral Cavernosum of Alloxan Induced Diabetic Rabbit
Park, J. K., Lee, S. O., Cui, W. S., Kim, S. Z., Koh, G. Y., & Cho, K. W. (2005) · European Urology · doi:10.1016/j.eururo.2005.06.017 · Cited by 7
Cyclo-Oxygenase Inhibition Restores the Attenuated Vasodilation in Manganese-Deficient Rat Aorta
Kalea, A. Z., Schuschke, D. A., Harris, P. D., & Klimis‐Zacas, D. J. (2006) · Journal of Nutrition · doi:10.1093/jn/136.9.2302 · Cited by 7
Carpal Tunnel Syndrome and Diabetes Surgical outcome and nerve pathology
Thomsen, N. (2009) · Lund University Publications (Lund University) · Cited by 7
Pham, T. P., Fukuda, D., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., Shimabukuro, M., & Sata, M. (2019) · Institutional Repositories DataBase (IRDB) · Cited by 7
Bordonado-Murcia, A., Marco-Lledó, J., Nieto-Gil, P., Zuluaga-Ríos, L. M., Ros, P. L., Hernández-Martínez, I., Montoro-Cremades, D., & Campos, J. G. (2025) · Diagnostics · doi:10.3390/diagnostics15070909 · Cited by 6
“This condition negatively impacts healing, leading to a considerably increased risk of amputation and mortality [6,9].”
Ravi, P. S., & Babu, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11246-z · Cited by 6
Xu, M. Q., Zheng, Y., Chen, X., Li, Y., Lin, W., & Zeng, B. (2020) · Biomedical Optics Express · doi:10.1364/boe.396817 · Cited by 6
Aktuğ, H., Çetintaş, V. B., Kosova, B., Oltulu, F., Demiray, S. B., Çavuşoğlu, T., Akarca, S. Ö., & Yavaşoğlu, A. (2012) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1104-38 · Cited by 6
Sahara, Y., Saito, S., & Ishikawa, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.030 · Cited by 6
Александровна, Т. О., Владимировна, К. С., Петрова, И. В., Ситожевский, А. В., Gruzdeva, O. V., Ivanov, V. V., & Суслова, Т. Е. (2009) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2009-2-56-60 · Cited by 6
Tyagi, S., Sharma, S., & Budhiraja, R. D. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-089 · Cited by 6
de Pouyade, G. D. L. R., Salciccia, A., Ceusters, J. D., Deby-Dupont, G. P., Serteyn, D. A., & Mouithys-Mickalad, A. A. (2011) · The Open Biochemistry Journal · doi:10.2174/1874091x01105010052 · Cited by 6
“Currently, I/R or ischemia / no reflow phenomenon injuries are involved as primary or secondary events in many human diseases [17-20].”
BackgroundDiabetes Mellitus and Cardiovascular Disease in the Elderly
Gregoratos, G., & Leung, G. (2008) · Fundamental and clinical cardiology · doi:10.3109/9781420061710.007 · Cited by 6
Genetic variants entail type 2 diabetes as an innate immune disorder
Bandesh, K., & Bharadwaj, D. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140458 · Cited by 6
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.